Keywords: Vectura. Developmental updates, Milestones, Asthma, COPD, Seebri Inhaler

Vectura updates on developmental products and milestones

Article | 15 August 2012

Print This

UK-based Vectura (LSE: VEC) saw its share price rise 4.9% to 75.50 pence yesterday morning, after the company published an Interim Management ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in